Scadden David
- SEC CIK
- 0001707715
In the past year, 3 open-market sale filings worth $25.0K and no purchases.
Current role at each company
- AGIO Agios Pharmaceuticals, Inc.Directoras of Jun 23, 2026
- EDIT Editas Medicine, Inc.Directoras of Jun 22, 2026
- CARM Carisma Therapeutics Inc.Directoras of Jul 1, 2024
- DNTH Dianthus Therapeutics, Inc.Directoras of Jun 30, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $25.0K
- 3 filings
- Net
- −$25.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Scadden David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AGIO Agios Pharmaceuticals, Inc.
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2024 (view filing) | Dec 11 | 2 days | Scadden DavidDirector | SSale | −200 | $46.28 | −$9.26K | −1.3%15.5K after | 10b5-1 |
| Jul 15, 2025 (view filing) | Jul 10 | 5 daysLate | Scadden DavidDirector | SSale | −1.40K | $40.00 | −$56.0K | −7.4%17.6K after | 10b5-1 |
| Aug 29, 2025 (view filing) | Aug 27 | 2 days | Scadden DavidDirector | SSale | −200 | $40.00 | −$8.00K | −1.1%17.6K after | 10b5-1 |
| Oct 2, 2025 (view filing) | Sep 30 | 2 days | Scadden DavidDirector | SSale | −200 | $40.00 | −$8.00K | −1.1%17.6K after | 10b5-1 |
| Oct 10, 2025 (view filing) | Oct 8 | 2 days | Scadden DavidDirector | SSale | −200 | $41.00 | −$8.20K | −1.1%17.6K after | 10b5-1 |
| Nov 14, 2025 (view filing) | Nov 12 | 2 days | Scadden DavidDirector | SSale | −200 | $43.84 | −$8.77K | −1.1%17.6K after | 10b5-1 |